Perspective · 10 Sep 2026
Conference abstractPublished 28 Sep 2015
Study the role of Urotensin II as a predictor for hepatorenal syndrome
Banha University, Egypt
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Hepatorenal syndrome (HRS type 1, 2) is one of the serious complications of chronic liver disease with high mortality. The Aim: Of this study was to evaluate the diagnostic role of urotensin II in patients with chronic liver diseases ( both ascitic and non ascitic patients). Forty patients were selected, Group (1) 20 patients with ascites (9 males and 11 females). Group (2) 20 patients without ascites (8 males and 12 females) their age and sex matched. Results: For ALT, T.B, DB serum urea and platelet count, there was a statistically significant decrease between the 2 groups ( p<0.05). The Ultrasound findings of the kidney’s were of statistically significant difference between the two groups as regard nephropathy (8 patients in ascitic group [1] while one patient in non ascitic group [2]) (p value <0.05). There was a statistically significant correlation between Urotensin II and blood urea level in group 2, The cut-off value of Urotensin II was of sensitivity 66.7%, specificity 64.5%, PPV 35.3% and NPP 86.96% with Accuracy 59% and p value <0.42 of no statistically significant difference. Conclusion: Urotensin II was of statistically significant positive correlation with blood urea level in patients without ascites, that means the relevant clinical importance to use urotensin II in the early stages of liver disease, that is of crucial prognostic important for follow up.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Reda M EL-Badawy”
